Physician profile
Michael M Gross
NPI 1639263130
$9,721.88
in general payments reported to CMS, 2019-2025
44 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,021 · 2020: $822 · 2021: $824 · 2022: $1,442 · 2023: $1,713 · 2024: $1,558 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,608 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,608.08 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,536.67 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $1,250.07 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,187.63 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Pfizer INC. | $630.77 | 2019-2025 | |
| Abbvie INC. | $591.26 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $563.42 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $510.88 | 2019-2025 | |
| Urovant Sciences INC | $289.95 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $289.84 | 2019-2023 | Edex, Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $281.07 | 2020-2024 | Lynparza, Keytruda |
| Ferring Pharmaceuticals INC. | $248.77 | 2019-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $239.80 | 2019-2022 | |
| Allergan, INC. | $219.83 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $161.81 | 2019-2020 | |
| Amgen INC. | $135.32 | 2019-2021 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $114.31 | 2023-2025 | Pylarify |
| Photocure INC | $109.47 | 2019-2025 | Cysview |
| Endo USA, INC. | $102.94 | 2024-2025 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $102.31 | 2020-2024 | Rezum Generator |
| Blue Earth Diagnostics | $91.42 | 2019-2022 | |
| Accord Healthcare, INC. | $87.58 | 2022-2024 | |
| Verity Pharmaceuticals INC. | $83.63 | 2023-2025 | Trelstar, Tlando |
| Coloplast Corp | $82.74 | 2019-2025 | |
| Clarus Therapeutics INC. | $82.23 | 2021 | |
| Alnylam Pharmaceuticals INC. | $79.39 | 2023 | Givlaari |
| Aytu Biopharma, INC. | $70.20 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $64.82 | 2022-2024 | Yonsa |
| Tolmar, INC. | $54.55 | 2023 | |
| Teleflex LLC | $54.16 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $52.21 | 2022 | |
| Urogen Pharma, INC. | $46.08 | 2023-2025 | Jelmyto |
| Dentsply Ih INC. | $45.44 | 2019-2020 | |
| Neotract INC. | $42.46 | 2019 | |
| Myovant Sciences INC. | $39.38 | 2022 | |
| Srs Medical Systems, INC. | $28.65 | 2024-2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Hollister Incorporated | $25.32 | 2023 | Onli, Vapro Pocket |
| Lantheus Medical Imaging, INC. | $24.43 | 2024 | |
| 180 Medical, INC. | $19.81 | 2019 | |
| Immunitybio, INC. | $16.79 | 2025 | |
| Acerus Pharmaceuticals Corporation | $14.56 | 2022 | |
| Laborie Medical Technologies Corp. | $14.23 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $12.46 | 2022 | |
| Metuchen Pharmaceuticals | $11.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.